D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 58 Citations 11,881 140 World Ranking 1319 National Ranking 51

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Internal medicine
  • Acquired immunodeficiency syndrome

Rob Schuurman mainly investigates Virology, Drug resistance, Virus, Viral load and Immunology. The concepts of his Virology study are interwoven with issues in RNA, Reverse transcriptase and Polymerase chain reaction. His work in Drug resistance covers topics such as Pharmacology which are related to areas like Cohort study.

The various areas that he examines in his Virus study include Multiplex, Combination therapy and Microbiology. His work deals with themes such as Cross-sectional study, Sida, Acquired immunodeficiency syndrome, Resistance mutation and Pediatrics, which intersect with Viral load. His work focuses on many connections between Immunology and other disciplines, such as Epidemiology, that overlap with his field of interest in Transmission, Common cold and Respiratory tract.

His most cited work include:

  • Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC) (455 citations)
  • Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR (420 citations)
  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management (389 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Virology, Immunology, Viral load, Drug resistance and Virus. The Virology study combines topics in areas such as RNA, Reverse transcriptase and Polymerase chain reaction. His Immunology study combines topics in areas such as Acquired immunodeficiency syndrome, Stem cell and Transplantation.

His research in Viral load intersects with topics in Surgery, Cross-sectional study, Reverse-transcriptase inhibitor, Human cytomegalovirus and Dried blood spot. His research in Drug resistance focuses on subjects like Internal medicine, which are connected to Oncology and Gastroenterology. His Virus research includes elements of Real-time polymerase chain reaction and Microbiology.

He most often published in these fields:

  • Virology (55.14%)
  • Immunology (26.17%)
  • Viral load (23.83%)

What were the highlights of his more recent work (between 2014-2021)?

  • Virology (55.14%)
  • Internal medicine (17.76%)
  • Drug resistance (23.36%)

In recent papers he was focusing on the following fields of study:

Virology, Internal medicine, Drug resistance, Virus and Viral load are his primary areas of study. Rob Schuurman has researched Virology in several fields, including Nucleic acid amplification technique, RNA, Molecular biology, Molecular diagnostics and Genotype. His studies in Internal medicine integrate themes in fields like HIV drug resistance and Antigen.

The concepts of his Drug resistance study are interwoven with issues in Mutation, Pyrosequencing, Drug levels and Dolutegravir. His studies in Virus integrate themes in fields like Hematopoietic stem cell transplantation, Nucleic acid and DNA. Viral load is a subfield of Immunology that Rob Schuurman studies.

Between 2014 and 2021, his most popular works were:

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing (87 citations)
  • A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. (56 citations)
  • HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy. (41 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Internal medicine
  • Acquired immunodeficiency syndrome

Rob Schuurman spends much of his time researching Virology, Internal medicine, Viral load, Drug resistance and Virus. His Virology research includes themes of Nucleic acid amplification technique, T cell, Immunology, Neisseria gonorrhoeae and Ceftriaxone. His work deals with themes such as Endemic area and Antigen, which intersect with Internal medicine.

His biological study spans a wide range of topics, including Odds ratio, Nested case-control study, HIV drug resistance and Regimen. His Drug resistance study integrates concerns from other disciplines, such as Somatic hypermutation, Cytidine deamination, Mutation, Pyrosequencing and Gastroenterology. Rob Schuurman has included themes like Cochrane Library, Confidence interval, Molecular diagnostics and Respiratory system in his Virus study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR

L. J. R. van Elden;M. Nijhuis;P. Schipper;R. Schuurman.
Journal of Clinical Microbiology (2001)

652 Citations

Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper.
The Journal of Infectious Diseases (1995)

582 Citations

Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)

558 Citations

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

Monique Nijhuis;Rob Schuurman;Dorien de Jong;John Erickson.
AIDS (1999)

505 Citations

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.

C. A. B. Boucher;N. Cammack;P. Schipper;R. Schuurman.
Antimicrobial Agents and Chemotherapy (1993)

433 Citations

IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection

Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman.
Journal of Immunology (2004)

371 Citations

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

Roos E Barth;Maarten F Schim van der Loeff;Rob Schuurman;Andy I M Hoepelman.
Lancet Infectious Diseases (2010)

338 Citations

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

Raph L Hamers;Carole L Wallis;Cissy Kityo;Margaret Siwale.
Lancet Infectious Diseases (2011)

321 Citations

Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert.
The Journal of Infectious Diseases (2009)

292 Citations

Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.

Rob Schuurman;Lisa Demeter;Patricia Reichelderfer;Jolanda Tijnagel.
Journal of Clinical Microbiology (1999)

284 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rob Schuurman

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 100

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 90

Charles A. Boucher

Charles A. Boucher

Erasmus University Rotterdam

Publications: 86

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 73

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 65

Deenan Pillay

Deenan Pillay

University College London

Publications: 60

Anders Sönnerborg

Anders Sönnerborg

Karolinska Institute

Publications: 54

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 53

Jan Albert

Jan Albert

Karolinska Institute

Publications: 50

Kristel Van Laethem

Kristel Van Laethem

Rega Institute for Medical Research

Publications: 49

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 48

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 48

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 47

Lisa M. Frenkel

Lisa M. Frenkel

Seattle Children's Hospital

Publications: 47

David Katzenstein

David Katzenstein

Stanford University

Publications: 43

Diane Descamps

Diane Descamps

Université Paris Cité

Publications: 42

Trending Scientists

Helen Lingard

Helen Lingard

RMIT University

Gilles Savard

Gilles Savard

Polytechnique Montréal

Marc Barthelemy

Marc Barthelemy

School for Advanced Studies in the Social Sciences

Concepció Rovira

Concepció Rovira

Institut de Ciència de Materials de Barcelona

Qi Shen

Qi Shen

Soochow University

Setsuko Komatsu

Setsuko Komatsu

Fukui University of Technology

Vincent W. Yang

Vincent W. Yang

Stony Brook University

Sarah E. Metcalfe

Sarah E. Metcalfe

University of Nottingham

Nicola Principi

Nicola Principi

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Arnaud D'Argembeau

Arnaud D'Argembeau

University of Liège

Francesca Simion

Francesca Simion

University of Padua

Derrick Silove

Derrick Silove

UNSW Sydney

Michael A. Kuskowski

Michael A. Kuskowski

University of Minnesota

Robert J. Lewandowski

Robert J. Lewandowski

Northwestern University

Greta R. Bauer

Greta R. Bauer

University of Western Ontario

Michiel Min

Michiel Min

Netherlands Institute for Space Research

Something went wrong. Please try again later.